vimarsana.com
Home
Live Updates
Misleading Results in Colchicine COVID-19 Trials Meta-Analysis : vimarsana.com
'Misleading' Results in Colchicine COVID-19 Trials Meta-Analysis
In a meta-analysis of six studies evaluating colchicine as a COVID-19 treatment, the anti-inflammatory drug for acute gout attacks did not appear to improve outcomes for patients.
Related Keywords
Greece ,
Brazil ,
Iran ,
New York ,
United States ,
India ,
Vadodara ,
Gujarat ,
Russia ,
Michaelh Pillinger ,
Kedar Gautambhai Mehta ,
Grossman School Of Medicine ,
Medscape Coronavirus Resource Center ,
College Gotri ,
Coronavirus Resource ,
Randomised Evaluation ,
Gautambhai Mehta ,
Very Different ,
Coronavirus ,
019 Novel Coronavirus ,
019 Ncov ,
Uhan Coronavirus ,
Uman Coronavirus Hku1 ,
Uman Coronavirus Oc43 ,
Cov Oc43 ,
Uman Coronavirus 229e ,
Cov 229e ,
Meta Analysis ,
Covid 19 Treatment ,
Health Care Quality Access Evaluation ,
Social Determinants Of Health ,
Anti Inflammatory Agents ,
Internship ,
Interns ,
Intensive Care Unit Icu ,
Intensive Care Unit ,
Icu ,
Intensive Care ,
Mechanical Ventilation ,
Fire ,
vimarsana.com © 2020. All Rights Reserved.